tiprankstipranks
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF
Holding MEDIF?
Track your performance easily

MediPharm Labs (MEDIF) Technical Analysis

408 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
1Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
MediPharm Labs’s (MEDIF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting MediPharm Labs is a Buy.
MediPharm Labs’s (MEDIF) 20-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.
MediPharm Labs’s (MEDIF) 50-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.

MediPharm Labs (MEDIF) Pivot Points

Dec 22, 2024, 08:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.04
0.04
0.04
0.04
0.05
0.05
Fibonacci
0.04
0.04
0.04
0.04
0.04
0.04
0.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MediPharm Labs (MEDIF) Moving Averages

Dec 22, 2024, 08:31 AM
Period
Simple
Exponential
MA5
0.04Buy
0.04Sell
MA10
0.04Sell
0.04Sell
MA20
0.05Sell
0.05Sell
MA50
0.05Sell
0.05Sell
MA100
0.05Sell
0.05Sell
MA200
0.05Sell
0.05Sell
MediPharm Labs’s (MEDIF) 10-Day exponential moving average is 0.04, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.
MediPharm Labs’s (MEDIF) 100-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 50-day simple moving average is 0.05, creating a Sell signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 100-day simple moving average is 0.05, creating a Sell signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 200-day simple moving average is 0.05, creating a Sell signal.

MediPharm Labs (MEDIF) Technical Indicators

Dec 22, 2024, 08:31 AM
Name
Value
Implied Action
RSI (14)
36.92
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
13.78
Buy
Williams %R
-100.00
Buy
CCI (14)
-137.14
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
26.20
Sell
ROC
-20.00
Sell
MediPharm Labs’s (MEDIF) Relative Strength Index (RSI) is 36.92, creating a Neutral signal.
MediPharm Labs’s (MEDIF) Trend Strength Indicator (ADX) is 13.78, creating a Buy signal.
MediPharm Labs’s (MEDIF) Commodity Channel Index (CCI) is -137.14, creating a Buy signal.
MediPharm Labs’s (MEDIF) Price Rate of Change (ROC) is -20.00, creating a Sell signal.

FAQ

Is MEDIF a Buy, Hold, or Sell?
Based on MEDIF’s technical indicators, MEDIF is a Sell.
    What is MEDIF’s RSI (14)?
    MEDIF’s RSI (14) is 36.92, which suggests MEDIF is a Neutral.
      What is MEDIF’s MACD?
      MEDIF’s MACD is >-0.01, which suggests MEDIF is a Buy.
        What is MEDIF’s 5-day moving average?
        MEDIF’s 5-day moving average is 0.04, which suggests MEDIF is a Buy.
          What is MEDIF’s 20-day moving average?
          MEDIF 20-day moving average is 0.05, which suggests MEDIF is a Sell.
            What is MEDIF’s 50-day moving average?
            MEDIF’s 50-day moving average is 0.05, which suggests MEDIF is a Sell.
              What is MEDIF’s 200-day moving average?
              MEDIF’s 200-day moving average is 0.05, which suggests MEDIF is a Sell.
                What is MEDIF’s Williams % R (14)?
                MEDIF’s Williams % R (14) is -100.00, which suggests MEDIF is a Buy.
                  What is MEDIF’s CCI (14)?
                  MEDIF’s CCI (14) is -137.14, which suggests MEDIF is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis